Market Overview:
The global Polygeline injection market is expected to grow at a CAGR of 4.0% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of chronic diseases, rising geriatric population, and technological advancements in the field of medical devices. Based on type, the global Polygeline injection market is segmented into 4.0% content, 3.5% content, and 3.2% content segments.
Product Definition:
Polygeline is an injectable filler used to fill in moderate to severe wrinkles and lines. It is a hyaluronic acid-based filler, meaning it helps to plump the skin by binding with water molecules. This can help to improve skin elasticity and reduce the appearance of lines and wrinkles. Polygeline is also longer-lasting than some other dermal fillers, typically lasting around 12 months.
4.0% Content:
4.0% content is a solution of dextrose in water, which is used as a diluent for the preparation of polyglycolic acid (PGA) and other glycolic acid-based injectable formulations. It has no medical use on its own; however, it can be used with other solutions or drugs to make injectable formulations that have more than one therapeutic effect.
3.5% Content:
3.5% content is a solution of hydrogen peroxide and water used for bleaching cotton, rayon, and other synthetic fibers. It is also used as a catalyst in the production of polymeric materials such as plastics & resins.
Application Insights:
The preoperative prevention segment held the largest market share in 2017. This is attributed to the growing incidence of chronic diseases, such as cardiovascular diseases, cancer and diabetes. According to a study published by NCBI in 2018, it was observed that around 1 out of every 2 deaths occur due to CVDs globally. Moreover, according to WHO data published in 2019, around 17 million people die from CVDs annually worldwide with about 60% of these deaths occurring in low- and middle-income countries. Thus, increasing awareness about preventive healthcare is resulting into increased demand for polygeline injections across the globe.
Extracorporeal circulation and dialysis are other applications anticipated to witness significant growth over the forecast period owing to rising patient admissions for ECCD procedures across various regions including Europe and North America.
Regional Analysis:
Asia Pacific dominated the global market in 2017 and is expected to maintain its position over the forecast period. The presence of a large number of key players, availability of advanced technologies, rising healthcare spending by consumers and government as well as increasing demand for organ transplantation are some factors contributing to regional growth.
The Asia Pacific region is home to several emerging economies including China, India, Indonesia & Malaysia which have been experiencing strong economic growth over the past few years. This has resulted in an increase in disposable income that can be used for medical purposes thereby driving demand for polyline products across this region.
In 2016 alone there were nearly 1 million donations from U.S., U.
Growth Factors:
- Increasing demand for Polygeline Injection from the medical industry for use in surgeries and other treatments.
- Growing research and development activities for new applications of Polygeline Injection in various industries.
- Rising awareness about the benefits of Polygeline Injection among consumers, which is likely to boost its demand over the forecast period.
- Technological advancements that have led to the development of novel products with better properties are expected to fuel market growth over the next few years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Polygeline Injection Market Research Report
By Type
4.0% Content, 3.5% Content, 3.2% Content
By Application
Preoperative prevention, Extracorporeal circulation and dialysis
By Companies
BBraun, Abbott, Wuhan Hualong, Conler Pharm, BBCA Pharm, Shengtai Pharm, Fuzhou Haiwang Fuyao, Chongqing Dikang Changjiang, Wuhan Daan
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
215
Number of Tables & Figures
151
Customization Available
Yes, the report can be customized as per your need.
Global Polygeline Injection Market Report Segments:
The global Polygeline Injection market is segmented on the basis of:
Types
4.0% Content, 3.5% Content, 3.2% Content
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Preoperative prevention, Extracorporeal circulation and dialysis
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- BBraun
- Abbott
- Wuhan Hualong
- Conler Pharm
- BBCA Pharm
- Shengtai Pharm
- Fuzhou Haiwang Fuyao
- Chongqing Dikang Changjiang
- Wuhan Daan
Highlights of The Polygeline Injection Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 4.0% Content
- 3.5% Content
- 3.2% Content
- By Application:
- Preoperative prevention
- Extracorporeal circulation and dialysis
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Polygeline Injection Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Polygeline injection is a type of medical injection that uses polyethylene glycol (PEG) as the solvent. Polygeline injections are used to treat pain and inflammation in various parts of the body.
Some of the key players operating in the polygeline injection market are BBraun, Abbott, Wuhan Hualong, Conler Pharm, BBCA Pharm, Shengtai Pharm, Fuzhou Haiwang Fuyao, Chongqing Dikang Changjiang, Wuhan Daan.
The polygeline injection market is expected to register a CAGR of 4%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Polygeline Injection Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Polygeline Injection Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Polygeline Injection Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Polygeline Injection Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Polygeline Injection Market Size & Forecast, 2018-2028
4.5.1 Polygeline Injection Market Size and Y-o-Y Growth
4.5.2 Polygeline Injection Market Absolute $ Opportunity
Chapter 5 Global Polygeline Injection Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Polygeline Injection Market Size Forecast by Type
5.2.1 4.0% Content
5.2.2 3.5% Content
5.2.3 3.2% Content
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Polygeline Injection Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Polygeline Injection Market Size Forecast by Applications
6.2.1 Preoperative prevention
6.2.2 Extracorporeal circulation and dialysis
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Polygeline Injection Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Polygeline Injection Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Polygeline Injection Analysis and Forecast
9.1 Introduction
9.2 North America Polygeline Injection Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Polygeline Injection Market Size Forecast by Type
9.6.1 4.0% Content
9.6.2 3.5% Content
9.6.3 3.2% Content
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Polygeline Injection Market Size Forecast by Applications
9.10.1 Preoperative prevention
9.10.2 Extracorporeal circulation and dialysis
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Polygeline Injection Analysis and Forecast
10.1 Introduction
10.2 Europe Polygeline Injection Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Polygeline Injection Market Size Forecast by Type
10.6.1 4.0% Content
10.6.2 3.5% Content
10.6.3 3.2% Content
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Polygeline Injection Market Size Forecast by Applications
10.10.1 Preoperative prevention
10.10.2 Extracorporeal circulation and dialysis
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Polygeline Injection Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Polygeline Injection Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Polygeline Injection Market Size Forecast by Type
11.6.1 4.0% Content
11.6.2 3.5% Content
11.6.3 3.2% Content
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Polygeline Injection Market Size Forecast by Applications
11.10.1 Preoperative prevention
11.10.2 Extracorporeal circulation and dialysis
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Polygeline Injection Analysis and Forecast
12.1 Introduction
12.2 Latin America Polygeline Injection Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Polygeline Injection Market Size Forecast by Type
12.6.1 4.0% Content
12.6.2 3.5% Content
12.6.3 3.2% Content
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Polygeline Injection Market Size Forecast by Applications
12.10.1 Preoperative prevention
12.10.2 Extracorporeal circulation and dialysis
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Polygeline Injection Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Polygeline Injection Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Polygeline Injection Market Size Forecast by Type
13.6.1 4.0% Content
13.6.2 3.5% Content
13.6.3 3.2% Content
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Polygeline Injection Market Size Forecast by Applications
13.10.1 Preoperative prevention
13.10.2 Extracorporeal circulation and dialysis
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Polygeline Injection Market: Competitive Dashboard
14.2 Global Polygeline Injection Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 BBraun
14.3.2 Abbott
14.3.3 Wuhan Hualong
14.3.4 Conler Pharm
14.3.5 BBCA Pharm
14.3.6 Shengtai Pharm
14.3.7 Fuzhou Haiwang Fuyao
14.3.8 Chongqing Dikang Changjiang
14.3.9 Wuhan Daan
